Singapore markets open in 4 hours 41 minutes
Straits Times Index
3,289.42 -23.93 (-0.72%) S&P 500
5,308.15 +61.47 (+1.17%) Dow
39,908.00 +349.89 (+0.88%) Nasdaq
16,742.39 +231.21 (+1.40%) Bitcoin USD
65,827.28 +4,236.37 (+6.88%) CMC Crypto 200
1,391.46 +123.51 (+9.73%)
Vertex Pharmaceuticals Incorporated (VRTX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 428.59 |
| Open | 430.93 |
| Bid | 437.39 x 100 |
| Ask | 437.71 x 100 |
| Day's range | 428.62 - 439.15 |
| 52-week range | 320.01 - 448.40 |
| Volume | |
| Avg. volume | 1,023,132 |
| Market cap | 113.249B |
| Beta (5Y monthly) | 0.39 |
| PE ratio (TTM) | 28.35 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Here's Why Vertex Pharmaceuticals (VRTX) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- GuruFocus.com
Alpine Immune Sciences Inc (ALPN) Reports Q1 2024 Financials Amid Pending Acquisition by Vertex ...
Financial Performance Aligns with Analyst Projections Despite Revenue Dip
- Zacks
CRISPR's (CRSP) Q1 Loss Narrower-Than-Expected, Sales Miss
CRISPR Therapeutics (CRSP) reports mixed earnings results for first-quarter 2024. Management claims that the commercial launch for the first ever CRISPR-based gene therapy is progressing well.
© 2024 Yahoo. All rights reserved.